MétaCan
Menu
Back to cohort
Record W4396998415 · doi:10.1681/asn.20203110s1594c

Use of Therapeutic Drug Monitoring Does Not Add Clinical Value for Voclosporin in Patients with Lupus Nephritis

2020· article· en· W4396998415 on OpenAlexaff
Teun van Gelder, Robert B. Huizinga, Jan Noukens, Laura Lisk, Neil Solomons

Bibliographic record

VenueJournal of the American Society of Nephrology · 2020
Typearticle
Languageen
FieldMedicine
TopicSystemic Lupus Erythematosus Research
Canadian institutionsAurinia (Canada)
Fundersnot available
KeywordsLupus nephritisMedicineDrugIntensive care medicineTherapeutic drug monitoringNephritisSystemic lupus erythematosusInternal medicinePharmacologyDisease

Abstract

fetched live from OpenAlex

Background: In a phase III clinical trial in patients with active lupus nephritis (LN), patients treated with 23.7 mg voclosporin bid in combination with MMF, achieved renal response rates of 40.8% vs. 22.5% for the control arm (OR 2.65; p < 0.001). The dose of voclosporin (VCS) was adjusted in response to decreases in eGFR. The objective of the present analysis was to evaluate the potential added value for therapeutic drug monitoring (TDM) in the LN patient population Methods: Pharmacokinetic (PK) data was analyzed from patients with LN treated with VCS. Based on a population PK model, the influence of various covariates on the disposition of voclosporin was evaluated. Calcineurin inhibition (CNI) was estimated using concentration data in the LN population and previously measured inhibition. Obtained exposure were put into perspective of renal response and the established safety margin Results: Sex, body weight, race, age, serum albumin, total bilirubin and eGFR demonstrated no significant or clinically relevant effect on the PK parameters. VCS has linear PK, and the goodness-of-fit plots (Figure 1 a/b) indicate that the model adequately describes observed and predicted concentrations of VCS. A strong correlation between VCS concentration and calcineurin inhibition is observed. VCS inhibits calcineurin in a dose-dependent manner up to maximum of 64 mg bid. In healthy subjects, a 96 mg bid dose was considered to be the upper limit of tolerability though did not present any safety concerns. At the 4-fold lower therapeutic dose of 23.7 mg bid, CNI was estimated to be 15.7% at Ctrough and 58.1% at Cmax. In a quartile exposure analysis, no relationship with the odds ratio for renal response was observed and favored VCS in all quartiles Conclusions: At a therapeutic dose of 23.7 mg bid, sex, body weight, race, age, serum albumin, total bilirubin and eGFR demonstrated no clinically relevant effect on VCS PK parameters. The linear PK profile of VCS allows the use of a pharmacodynamic approach instead of a pharmacokinetic approach, in which the dose of VCS is adjusted in response to decreases in eGFR. These data suggest that TDM is unlikely to be of added benefit to patient management

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.006
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.057
GPT teacher head0.340
Teacher spread0.283 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations9
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the American Society of NephrologySame topicSystemic Lupus Erythematosus ResearchFrench-language works237,207